Study wrapper · #626
State of Colon Microbiota in Rats during Chronic Restraint Stress and Selank Treatment.
Editor's note
This is a preclinical rodent study, not clinical evidence. Researchers subjected male Wistar rats to chronic restraint stress and gave Selank intraperitoneally at 80, 250, or 750 microg/kg before the stressor. They reported that stress shifted the colon microbiota — reducing obligate flora and increasing opportunistic organisms — and that Selank administration was associated with a restoration of that balance, which the authors attribute to combined central and peripheral mechanisms. For Selank, a Russian-developed tuftsin analog with a mainly anxiolytic and immunotropic literature, this fits the emerging gut-brain-axis framing but does not establish it. Weigh it as a single-model mechanistic signal: no dose-response detail is reported here, the microbiota measures are group-level, and there is no human counterpart. These are preclinical findings; human data are needed before any clinical conclusions can be drawn.
Plain-language abstract
Selank is a lab-made peptide studied mostly for anxiety and immune effects. In this animal experiment, male rats were repeatedly restrained to create chronic stress, and some received Selank as an injection into the abdomen (at three different doses) shortly before each stress session. The researchers looked at the mix of bacteria in the rats' colons. Chronic stress alone lowered the helpful, normally-present bacteria and raised the potentially harmful ones. In rats given Selank, the bacterial balance looked closer to normal. The authors suggest Selank may act both through the nervous system and through the immune system to produce this effect. This was a study in rats, not people, and it measured bacteria at the group level without reporting side effects. It is an early mechanistic clue about how Selank might interact with gut bacteria under stress, not proof of any benefit in humans.